Your browser doesn't support javascript.
loading
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus.
Jiang, Simon H; Athanasopoulos, Vicki; Ellyard, Julia I; Chuah, Aaron; Cappello, Jean; Cook, Amelia; Prabhu, Savit B; Cardenas, Jacob; Gu, Jinghua; Stanley, Maurice; Roco, Jonathan A; Papa, Ilenia; Yabas, Mehmet; Walters, Giles D; Burgio, Gaetan; McKeon, Kathryn; Byers, James M; Burrin, Charlotte; Enders, Anselm; Miosge, Lisa A; Canete, Pablo F; Jelusic, Marija; Tasic, Velibor; Lungu, Adrian C; Alexander, Stephen I; Kitching, Arthur R; Fulcher, David A; Shen, Nan; Arsov, Todor; Gatenby, Paul A; Babon, Jeff J; Mallon, Dominic F; de Lucas Collantes, Carmen; Stone, Eric A; Wu, Philip; Field, Matthew A; Andrews, Thomas D; Cho, Eun; Pascual, Virginia; Cook, Matthew C; Vinuesa, Carola G.
Afiliação
  • Jiang SH; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia. Simon.jiang@anu.edu.au.
  • Athanasopoulos V; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia. Simon.jiang@anu.edu.au.
  • Ellyard JI; Department of Renal Medicine, The Canberra Hospital, Garran, 2601, ACT, Australia. Simon.jiang@anu.edu.au.
  • Chuah A; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Cappello J; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Cook A; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Prabhu SB; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Cardenas J; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Gu J; Genome Informatics Laboratory, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Stanley M; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Roco JA; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Papa I; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Yabas M; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Walters GD; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Burgio G; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • McKeon K; Paediatric Biology Center, Translational Health Science and Technology Institute, Faridabad, 121001, Haryana, India.
  • Byers JM; Baylor Medical Institute, Houston, 77030, Texas, USA.
  • Burrin C; Baylor Medical Institute, Houston, 77030, Texas, USA.
  • Enders A; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Miosge LA; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Canete PF; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Jelusic M; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Tasic V; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Lungu AC; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Alexander SI; Department of Genetics and Bioengineering, Trakya University, Edirne, 22030, Turkey.
  • Kitching AR; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Fulcher DA; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Shen N; Department of Renal Medicine, The Canberra Hospital, Garran, 2601, ACT, Australia.
  • Arsov T; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Gatenby PA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Babon JJ; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Mallon DF; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • de Lucas Collantes C; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Stone EA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Wu P; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Field MA; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Andrews TD; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Cho E; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Acton, 2601, ACT, Australia.
  • Pascual V; Centre for Personalised Immunology, NHMRC Centre for Research Excellence, Acton, 2601, Australia.
  • Cook MC; Department of Paediatric Rheumatology and Immunology, University of Zagreb School of Medicine, Zagreb, 10000, Croatia.
  • Vinuesa CG; University Children's Hospital, Medical School, Skopje, 1000, Macedonia.
Nat Commun ; 10(1): 2201, 2019 05 17.
Article em En | MEDLINE | ID: mdl-31101814
ABSTRACT
Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease. It is thought that many common variant gene loci of weak effect act additively to predispose to common autoimmune diseases, while the contribution of rare variants remains unclear. Here we describe that rare coding variants in lupus-risk genes are present in most SLE patients and healthy controls. We demonstrate the functional consequences of rare and low frequency missense variants in the interacting proteins BLK and BANK1, which are present alone, or in combination, in a substantial proportion of lupus patients. The rare variants found in patients, but not those found exclusively in controls, impair suppression of IRF5 and type-I IFN in human B cell lines and increase pathogenic lymphocytes in lupus-prone mice. Thus, rare gene variants are common in SLE and likely contribute to genetic risk.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases da Família src / Predisposição Genética para Doença / Proteínas Adaptadoras de Transdução de Sinal / Lúpus Eritematoso Sistêmico / Proteínas de Membrana Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases da Família src / Predisposição Genética para Doença / Proteínas Adaptadoras de Transdução de Sinal / Lúpus Eritematoso Sistêmico / Proteínas de Membrana Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Ano de publicação: 2019 Tipo de documento: Article